Amerise Biosciences Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported revenue was INR 0.057 million compared to INR 18.58 million a year ago. Net loss was INR 0.075 million compared to net income of INR 3.35 million a year ago.
For the six months, revenue was INR 0.086 million compared to INR 33.49 million a year ago. Net loss was INR 0.472 million compared to net income of INR 6.32 million a year ago. Basic loss per share from continuing operations was INR 0.01 compared to basic earnings per share from continuing operations of INR 0.1 a year ago. Diluted loss per share from continuing operations was INR 0.01 compared to diluted earnings per share from continuing operations of INR 0.1 a year ago.